IMC Chicago’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.29M Buy
235,900
+39,800
+20% +$208K ﹤0.01% 3753
2026
Q2
$1.24M Buy
196,100
+53,900
+38% +$264K ﹤0.01% 3735
2026
Q1
$486K Sell
142,200
-127,900
-47% -$431K ﹤0.01% 4282
2025
Q4
$764K Buy
270,100
+85,000
+46% +$438K ﹤0.01% 3325
2025
Q3
$1.29M Buy
185,100
+47,900
+35% +$338K ﹤0.01% 2656
2025
Q2
$812K Sell
137,200
-65,100
-32% -$374K ﹤0.01% 2739
2025
Q1
$1.29M Buy
202,300
+32,900
+19% +$317K ﹤0.01% 2210
2024
Q4
$2.01M Buy
169,400
+109,000
+180% +$1.86M ﹤0.01% 1962
2024
Q3
$1.67M Buy
60,400
+29,200
+94% +$731K ﹤0.01% 1865
2024
Q2
$744K Buy
31,200
+13,000
+71% +$305K ﹤0.01% 2223
2024
Q1
$320K Buy
+18,200
New +$268K ﹤0.01% 2328

Other funds holding ASPN

IMC Chicago's ASPN Position: Q2 2026 in Review

IMC Chicago sold out of Aspen Aerogels (ASPN) in Q2 2026, closing a stake of 22,470 shares — an estimated $110K sold.

IMC Chicago first reported a position in ASPN in Q2 2024 and held it in 8 quarters. The position peaked at $1.45M in Q4 2024. 180 funds tracked by Wall St. Rank hold ASPN as of Q2 2026.

  • IMC Chicago reported no remaining Aspen Aerogels position as of Q2 2026 after selling out during the quarter.
  • IMC Chicago sold 22,470 Aspen Aerogels shares in Q2 2026, an estimated $110K.
  • IMC Chicago first reported a position in Aspen Aerogels in Q2 2024 and held it in 8 quarters.
  • IMC Chicago's Aspen Aerogels position peaked at $1.45M in Q4 2024.
  • 180 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.